Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1070
-0.0060 (-5.31%)
Jun 1, 2026, 3:58 PM HKT
Market Cap189.61M -67.2%
Revenue (ttm)1.08B -6.7%
Net Income-45.33M
EPS-0.03
Shares Out 1.68B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume790,000
Open0.1130
Previous Close0.1130
Day's Range0.1040 - 0.1130
52-Week Range0.1020 - 0.2090
Beta-0.13
Analystsn/a
Price Targetn/a
Earnings DateMar 25, 2026

About HKG:8329

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. It operates through two segments, Manufacturing and Selling of medicines and medical devices; and Sales and Distribution of medicines and healthcare products, and medical devices. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, an... [Read more]

Sector Healthcare
Founded 2002
Employees 1,382
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8329
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements